Skip to content
Home/Companies/Biotech/Mimetic Medicines
Mimetic Medicines

Mimetic Medicines

Biotech·United States·Active
Entry
–
Hold
–
Status
Active

Who owns Mimetic Medicines?

Mimetic Medicines is an American Biotech company, currently owned by AgFunder.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
AgFunder
Investor
AgFunder
AgFunder Fund IV · 2024 · VC

Key facts

HQUnited States
SectorBiotech
Websitemimeticmedicines.com

More from AgFunder Fund IV

Other portfolio companies in the same fund.

3Bee
3Bee
Active
TMTUS
3bee 2
Active
AgTechUS
Ai Palette
Ai Palette
Active
AI/ML
Apeel Sciences
Active
AgTechUS
Aquaconnect
Active
TMTUS
Atinary
Atinary
Active
TMTUS

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Mimetic Medicines?

Mimetic Medicines is currently owned by AgFunder, through AgFunder Fund IV.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue